Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy

Journal of International Medical Research

Volumn 40, Issue 1, 2012, Pages 76-84

  Liu, Z L ^a   Zhou, Q ^a   Zeng, Qing Shi ^a   LI, C F ^a   Zhang, K ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Brain; Cerebral Glioma; Diffusion Weighted Imaging (DWI); Image Guided; Magnetic Resonance (MR); Proton Mr Spectroscopy; Tumour Grade

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; GADOLINIUM PENTETATE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOMA; HUMAN; MALE; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84863261455     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000108     Document Type: Article

References (28)

1. Dean BL, Drayer BP, Bird CR, et al: Gliomas: classification with MR imaging. Radiology 1990; 174: 411-415.
2. Möller-Hartmann W, Herminghaus S, Krings T, et al: Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002; 44: 371-381.
3. Law M, Yang S, Wang H, et al: Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24: 1989-1998.
4. Al-Okaili RN, Krejza J, Woo JH, et al: Intraaxial brain masses: MR imaging-based diagnostic strategy-initial experience. Radiology 2007; 243: 539-550.
5. Watanabe M, Tanaka R, Takeda N: Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992; 34: 463-469.
6. Kondziolka D, Lunsford LD, Martinez AJ: Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993; 79: 533-536.
7. Knopp EA, Cha S, Johnson G, et al: Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211: 791-798.
8. Meyerand ME, Pipas JM, Mamourian A, et al: Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol 1999; 20: 117-123.
9. Bulakbasi N, Kocaoglu M, Ors F, et al: Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003; 24: 225-233.
10. Gupta RK, Cloughesy TF, Sinha U, et al: Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000; 50: 215-226.
11. Bulakbasi N, Guvenc I, Onguru O, et al: The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004; 28: 735-746.
12. Provenzale JM, Mukundan S, Barboriak DP: Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006; 239: 632-649.
13. Bode MK, Ruohonen J, Nieminen MT, et al: Potential of diffusion imaging in brain tumors: a review. Acta Radiol 2006; 47: 585-594.
14. Higano S, Yun X, Kumabe T, et al: Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006; 241: 839-846.
15. Murakami R, Hirai T, Sugahara T, et al: Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a oneversus two-parameter pilot method. Radiology 2009; 251: 838-845.
16. Kitis O, Altay H, Calli C, et al: Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 2005; 55: 393-400.
17. Roberts TP, Rowley HA: Diffusion weighted magnetic resonance imaging in stroke. Eur J Radiol 2003; 45: 185-194.
18. Rumboldt Z, Camacho DL, Lake D, et al: Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006; 27: 1362-1369.
19. 2. AJNR Am J Neuroradiol 2008; 29: 458-463.
20. McKnight TR, von dem Bussche MH, Vigneron DB, et al: Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002; 97: 794-802.
21. 1H-MR spectroscopy. Diagn Interv Radiol 2007; 13: 3-9.
22. Stadlbauer A, Gruber S, Nimsky C, et al: Preoperative grading of gliomas by using metabolite quantification with high-spatialresolution proton MR spectroscopic imaging. Radiology 2006; 238: 958-969.
23. 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. AJNR Am J Neuroradiol 2006; 27: 1412-1418.
24. Soares DP, Law M: Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 2009; 64: 12-21.
25. Sandgren N, Selén Y, Stoica P, et al: Parametric methods for frequency-selective MR spectroscopy-a review. J Magn Reson 2004; 168: 259-272.
26. Zonari P, Baraldi P, Crisi G: Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 2007; 49: 795-803.
27. Toyooka M, Kimura H, Uematsu H, et al: Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation. Clin Imaging 2008; 32: 251-258.
28. Shimizu H, Kumabe T, Shirane R, et al: Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 2000; 21: 659-665.